Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Epic Sciences Inc.

Headquarters: San Diego, CA, United States of America
Year Founded: 2008
Status: Private

BioCentury | Jun 3, 2022
Deals

June 2 Quick Takes: BMS, Immatics expand partnership to allogeneic T cells

Plus Transition’s $50M A round, Centessa’s killed kidney program and updates from Centessa, Aeglea, Immunic and more
BioCentury | Oct 26, 2021
Management Tracks

Biden picks tech lawyer Vidal to head USPTO

Zaks joins Deep Genomics’ board, plus Akoya, Avrobio, Immunicum and more
BioCentury | Apr 22, 2019
Company News

Management tracks: MeiraGTx, Retrophin, Aduro

BioCentury | Mar 27, 2019
Company News

Management tracks: Epic, Axcella, KalVista

BioCentury | Sep 14, 2018
Financial News

Epic raises $52M series E

BioCentury | Sep 5, 2018
Company News

Management tracks: Agios, Radius

BioCentury | Apr 13, 2018
Targets & Mechanisms

Meeting the burden

New developments in TMB, synthetic lethality, oncolytic viruses & more at AACR18
BioCentury | Mar 6, 2018
Preclinical News

FNIH reviews single-cell analysis landscape

BioCentury | May 3, 2017
Financial News

Epic Sciences raises $40M in series D

Items per page:
1 - 10 of 25